Recherche - Archive ouverte HAL Accéder directement au contenu

Filtrer vos résultats

12 Résultats
Structure : Identifiant HAL de la structure : 498310

Outcome of a Salvage Third Autologous Stem Cell Transplantation in Multiple Myeloma

Laurent Garderet , Simona Iacobelli , Linda Koster , Hartmut Goldschmidt , Jan-Erik Johansson et al.
Biology of Blood and Marrow Transplantation, 2018, 24 (7), pp.1372-1378. ⟨10.1016/j.bbmt.2018.01.035⟩
Article dans une revue hal-01975406v1
Image document

Deep-Learning Assessed Muscular Hypodensity Independently Predicts Mortality in DLBCL Patients Younger Than 60 Years

Maxime Jullien , Benoit Tessoulin , Hervé Ghesquières , Lucie Oberic , Franck Morschhauser et al.
Cancers, 2021, 13 (18), pp.4503. ⟨10.3390/cancers13184503⟩
Article dans une revue inserm-03540506v1

STEM CELL COLLECTION AFTER FAILURE OF UPFRONT ABVD OR BEACOPP IN PATIENTS WITH HIGH RISK ADVANCED STAGE III-IV HODGKIN'S LYMPHOMA

D. Ghez , C. Fortpied , N. Mounier , P. Carde , A. Perrot et al.
Haematologica, 2016, 101 (5), pp.50
Article dans une revue hal-03605056v1
Image document

PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study

Rene-Olivier Casasnovas , Reda Bouabdallah , Pauline Brice , Julien Lazarovici , Hervé Ghesquieres et al.
Lancet Oncology, 2019
Article dans une revue hal-01996114v1

Immune stimulation during chemotherapy increases incidence of acute graft versus host disease in acute myeloid leukemia: A study on behalf of SFGM-TC and ALFA

Lining Wang , Emmanuel Raffoux , Xavier Thomas , Ibrahim Yakoub-Agha , Jean-Henri Bouhris et al.
Leukemia Research, 2017, 54, pp.12-16. ⟨10.1016/j.leukres.2017.01.002⟩
Article dans une revue hal-01557470v1

Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centers

Cédric Rossi , Julia Gilhodes , Marie Maerevoet , Charles Herbaux , Franck Morschhauser et al.
American Journal of Hematology, 2018, 93 (8), pp.1042-1049. ⟨10.1002/ajh.25154⟩
Article dans une revue hal-02050402v1
Image document

Outcomes of refractory or relapsed Hodgkin lymphoma patients with post autologous stem cell transplantation brentuximab vedotin maintenance : a French multicenter observational cohort study

Amira Marouf , Anne Segolene Cottereau , Salim Kanoun , Paul Deschamps , Michel Meignan et al.
Haematologica, 2022, 107 (7), pp.1681-1686. ⟨10.3324/haematol.2021.279564⟩
Article dans une revue hal-03628340v1

Randomized Phase II Study of Clofarabine-Based Consolidation for Younger Adults With Acute Myeloid Leukemia in First Remission.

Xavier Thomas , Stéphane de Botton , Sylvie Chevret , Denis Caillot , Emmanuel Raffoux et al.
Journal of Clinical Oncology, 2017, 35 (11), pp.1223-1230. ⟨10.1200/JCO.2016.70.4551⟩
Article dans une revue hal-01557436v1
Image document

Oxaliplatin before autologous transplantation in combination with high-dose cytarabine and rituximab provides longer disease control than cisplatin or carboplatin in patients with mantle-cell lymphoma: results from the LyMA prospective trial

Benoit Tessoulin , David Chiron , Catherine Thieblemont , Lucie Oberic , Kamal Bouadballah et al.
Bone Marrow Transplantation, 2021, 56 (7), pp.1700-1709. ⟨10.1038/s41409-020-01198-2⟩
Article dans une revue hal-03203334v1

Validation of response assessment according to international consortium for MDS/MPN criteria in chronic myelomonocytic leukemia treated with hypomethylating agents

M Duchmann , B Braun , J.B. Micol , P Platzbecker , P. Park et al.
Blood Cancer Journal, 2017, 7 (5), pp.e562. ⟨10.1038/bcj.2017.41⟩
Article dans une revue hal-01655936v1

Bendamustine-EAM versus R-BEAM after high-dose cytarabine-based induction in newly diagnosed patients with mantle cell lymphoma, a LYSA retrospective study

Domitille Costes-Tertrais , Thomas Hueso , Thomas Gastinne , Catherine Thieblemont , Lucie Oberic et al.
Bone Marrow Transplantation, 2022, ⟨10.1038/s41409-022-01596-8⟩
Article dans une revue hal-03608256v1

PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study

Rene-Olivier Casasnovas , Reda Bouabdallah , Pauline Brice , Julien Lazarovici , Hervé Ghesquieres et al.
Lancet Oncology, 2019, 20 (2), pp.202-215. ⟨10.1016/S1470-2045(18)30784-8⟩
Article dans une revue hal-02263798v1